| Literature DB >> 26543326 |
Calliandra de Souza Silva1, Aldo Henrique Tavares2, Marcio Sousa Jeronimo2, Yasmin Soares de Lima2, Lorena da Silveira Derengowski1, Anamélia Lorenzetti Bocca2, Ildinete Silva-Pereira1.
Abstract
Considering the importance of macrophages as the first line of defense against fungal infection and the different roles played by the two M1- and M2-like polarized macrophages, we decided to evaluate the effects of Paracoccidioides brasiliensis infection on GM-CSF- and M-CSF-induced bone marrow-derived macrophages (BMM) from the A/J and B10.A mouse strains, an established model of resistance/susceptibility to PCM, respectively. Upon differentiation, the generated GM- or M-BMMs were characterized by morphological analyses, gene expression profiles, and cytokines production. Our main results demonstrate that GM-BMMs derived from A/J and B.10 produced high levels of pro- and anti-inflammatory cytokines that may contribute to generate an unbalanced early immune response. In accordance with the literature, the B10.A susceptible mice lineage has an innate tendency to polarize into M1-like phenotype, whereas the opposite phenotype occurs in A/J resistance mice. In this context, our data support that susceptibility and resistance are strongly correlated with M1 and M2 polarization, respectively.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26543326 PMCID: PMC4620243 DOI: 10.1155/2015/605450
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Figure 1Characterization of GM-BMM and M-BMM of A/J and B10.A mice. Murine bone marrow cells were differentiated into macrophages (BMM) in the presence of GM-CSF (GM-BMM) or M-CSF (M-BMM) as described in Section 2. (a) Photomicrography of GM-BMM and M-BMM from A/J and B10.A mouse strains stained with Panotic kit (×200). (b) Quantitative PCR analysis (qRT-PCR) of induced nitric oxide synthase (iNOS) or Arginase-1 (ARG-1) mRNA expression from GM-BMM or M-BMM. Bars with SD represent the mean of fold change of the gene expression and are shown as n-fold difference of GM-BMM to the M-BMM cells. Fold change values were determined after each gene was normalized to the constitutively expressed rps9 gene. Data is representative of three separate experiments. (c) qRT-PCR analysis of Clec7a, Ilr1, Ptx3, Cxcl3, or Il10 mRNA expression from GM-BMM or M-BMM. Bars represent the mean of fold gene expression and are shown as n-fold difference of GM-BMM to the M-BMM cells. Fold change values were determined after each gene was normalized to the constitutively expressed Gusb (A/J) and B2m (B10.A) genes using the comparative threshold method.
Figure 2Ratio of internalized/adhered P. brasiliensis yeast cell by GM-BMMs and M-BMMs of A/J and B10.A mouse strains. Phagocytosis assays were performed employing a MOI (multiplicity of infection) of 5 : 1 macrophage to P. brasiliensis (Pb18) yeast cells, for incubation times of 6 h and 24 h. After the coculture, the cells were stained with Panotic kit. An average of 300 macrophages was counted and the number of ingested and/or adherent yeasts was determined. ( p ≤ 0.0001, p ≤ 0.001, p ≤ 0.01, and p ≤ 0.05).
Figure 3Expression profiling based on Mouse Antifungal Response RTC Profiler PCR Array. (a) A heat map was generated with 84 genes associated with antifungal immune response and five housekeeping genes, using RT2 Profiler Data Analysis Software version 3.5 with the PAMM 00147Z array panel (SABiosciences). Fold change values were determined after each gene was normalized to the constitutively expressed Gusb (A/J) and B2m (B10.A) genes using the comparative threshold method. AIGs 1, 2, and 3 and AIMs 1, 2, and 3 stand for A/J GM-BMM and M-BMM, respectively, infected with P. brasiliensis in relation to its respective control cells. BIGs 1, 2, and 3 and BIMs 1, 2, and 3 stand for B10.A GM-BMM and M-BMM, respectively, infected with P. brasiliensis in relation to its respective control cells. (b) Venn diagram summarizing the results of differentially expressed genes (p ≤ 0.05; fold change ≥2) between the noninfected and P. brasiliensis infected group of GM- or M-BMM of A/J and B10.A mice strains.
Comparison of differentially expressed genes in GM-BMM versus M-BMM of Paracoccidioides brasiliensis infected A/J and B10.A mice.
| Gene | Name | Fold changes (FC) | |||
|---|---|---|---|---|---|
| A/J | B10.A | ||||
| M-BMM + Pb18 versus M-BMM | GM-BMM + Pb18 versus GM-BMM | M-BMM + Pb18 versus M-BMM | GM-BMM + Pb18 versus GM-BMM | ||
| Pattern of recognition receptor (PRR) | |||||
| TLR2 | Toll-like receptor 2 | −1.7 | 1.4 |
|
|
| TLR4 | Toll-like receptor 4 | 1.2 | 1.0 | 1.4 |
|
| TLR9 | Toll-like receptor 9 | −1.7 | 1.3 | 1.1 |
|
| Clec4n (Dectin-2) | C-type lectin domain family 4, member n |
|
| 6.1 | 1.6 |
| Clec7a (Dectin-1) | C-type lectin domain family 7, member a |
|
|
| 1.1 |
| Mrc1 (MR) | Mannose receptor, C-type 1 |
| 2.0 | −1.7 | −2.7 |
| Nlrp3 | NLR family, pyrin domain containing 3 | 1.3 |
|
| −1.9 |
| Scarf1 | Scavenger receptor class F, member 1 |
| −1.2 | −1.7 | −2.1 |
| Itgb2 | Integrin beta 2 | −1.4 | 1.2 |
|
|
| Mbl2 | Mannose-binding protein (protein C) 2 | 1.8 | 1.2 |
|
|
| CD14 | CD14 antigen | 2.0 | 3.0 | −1.3 |
|
| Itgam | Integrin alpha M | −1.4 | 1.6 | 1.3 |
|
| Colec12 | Collectin subfamily member 12 |
| 1.8 |
| −1.1 |
| PRR signal Transduction | |||||
| Casp-8 | Caspase-8 | 1.5 |
| 1.3 | 1.6 |
| Irak4 | Interleukin-1 receptor-associated kinase 4 | 1.3 |
| 1.5 | −2.6 |
| Mapk14 | Mitogen-activated protein kinase 14 | 1.1 | 1.3 |
| −3.6 |
| Mapk8 | Mitogen-activated protein kinase 8 | −1.7 | 1.4 |
| −1.6 |
| MyD88 | Myeloid differentiation primary response gene 88 | 1.5 |
|
| −3.0 |
| Bcl10 | B-cell leukemia/lymphoma 10 |
|
| 1.6 | 2.0 |
| Malt1 | Mucosa associated lymphoid tissue lymphoma translocation gene 1 |
| 1.7 |
| −1.7 |
| Pycard | PYD and CARD domain containing |
| 1.3 | 1.7 |
|
| Plcg2 | Phospholipase C gamma 2 |
| −1.1 | 2.0 |
|
| Tirap (Mal) | Toll-interleukin-1 receptor (TIR) domain-containing adaptor protein | −1.1 | 1.3 | 1.4 |
|
| Raf1 | V-raf-leukemia viral oncogene 1 | 1.1 | 1.1 |
|
|
| Syk | Spleen tyrosine kinase | 1.5 | 1.3 |
|
|
| CD40 | CD40 antigen | −1.4 | 10.2 | 2.0 |
|
| Transcription factor and other proteins | |||||
| Map2k4 (MKK4) | Mitogen-activated protein kinase 4 | −1.3 | 1.8 | 1.9 |
|
| Mapk8 | Mitogen-activated protein kinase 8 | −1.7 | 1.4 |
| −1.6 |
| Nfkbia | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | −1.7 | 1.7 |
| 1.1 |
| Cytokines | |||||
| Csf2 (GM-CSF) | Colony stimulating factor 2 (granulocyte-macrophage) | −3.3 | 3.1 | −2.0 |
|
| Il1a | Interleukin-1 alpha |
|
|
|
|
| Il1b | Interleukin-1 beta | 1.8 |
|
|
|
| Il2 | Interleukin-2 | 1.3 |
|
|
|
| Il6 | Interleukin-6 | 1.0 |
| −1.4 |
|
| Il10 | Interleukin-10 | −1.8 |
| 1.5 |
|
| Il12a | Interleukin-12A | 1.3 |
| 1.8 | 3.5 |
| Il12b | Interleukin-12B | 1.5 |
| 1.5 |
|
| Il18 | Interleukin-18 | −1.2 |
| 1.0 | −1.3 |
| Il23a | Interleukin-23, alpha subunit p19 | 1.2 |
| 2.0 | 1.9 |
| Tnf | Tumor necrosis factor alpha | −1.0 |
| −1.1 |
|
| Chemokines | |||||
| Ccl5 | Chemokine (C-C motif) ligand 5 | 1.1 | 6.2 | 3.5 | 21.1 |
| Ccl12 | Chemokine (C-C motif) ligand 12 | −4.5 |
| 1.1 |
|
| Ccl20 | Chemokine (C-C motif) ligand 20 | −1.1 |
|
| 1.0 |
| Cxcl1 (KC) | Chemokine (C-X-C motif) ligand 1 |
|
|
|
|
| Cxcl3 | Chemokine (C-X-C motif) ligand 3 |
|
|
|
|
| Cxcl9 | Chemokine (C-X-C motif) ligand 9 |
|
| 1.5 | 3.7 |
| Cxcl10 (IP-10) | Chemokine (C-X-C motif) ligand 10 | −1.9 |
|
|
|
| Cxcl11 | Chemokine (C-X-C motif) ligand 11 |
| −1.2 |
| −1.3 |
| Other proteins | |||||
| Ptgs2 (Cox-2) | Prostaglandin-endoperoxide synthase 2 |
|
|
|
|
| Chia1 | Chitinase, acidic | −1.7 | −2.0 |
| −4.9 |
| Stat1 | Signal transducer and activator of transcription 1 |
|
| −1.1 | −2.6 |
| C3 | Complement component 3 |
|
|
| 1.1 |
| C5ar1 | Complement component 5a receptor 1 |
|
|
| 1.5 |
| Fcgr3 | Fc receptor, IgG, low affinity III |
| 1.4 | 1.5 | −1.3 |
Genes In bold lettering had their transcript levels significantly modulated (FC ≥ 2 or ≤ −2 and p value < 0.05 as described in Section 2). Positive and negative values represent genes with expression induced and repressed, respectively.
Figure 4Cytokines profile after 6 h of Paracoccidioides brasiliensis infection of GM- and M-BMMs from A/J and B10.A mouse strains. Cytokines levels produced by the two different BMMs of both mouse strains after infection with Pb18, by ELISA assay. Data are means ± SD of triplicate samples representative of three separate experiments ( p ≤ 0.0001, p ≤ 0.001, and p ≤ 0.01).
Figure 5Cytokines profile after 24 h of Paracoccidioides brasiliensis infection of GM- and M-BMMs from A/J and B10.A mouse strains. Cytokines levels produced by the two different BMMs of both mouse strains after infection with Pb18, by ELISA assay. Data are means ± SD of triplicate samples representative of three separate experiments ( p ≤ 0.0001, p ≤ 0.001, and p ≤ 0.01).
Figure 6Schematic representation of the major results of gene expression and cytokine production by GM- and M-BMM from A/J and B10.A mouse strains in response to in vitro Pb18 infection. The arrows indicate up- and downregulated genes. The yellow, red, green, and blue circles are representative of TNF-α, IL-10, MCP-1, and IL-6, respectively. The genes indicated in bold demonstrated a higher expression compared between GM- and M-BMM from the same mouse strain. The underlined genes indicated the same expression pattern between GM- and M-BMM from different mice strain.